The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()

por Dale, Philippa R, Cernecka, Hana, Schmidt, Martina, Dowling, Mark R, Charlton, Steven J, Pieper, Michael P, Michel, Martin C
Publicado 2014

Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells

por Yang, Nan, Singhera, Gurpreet K., Yan, Yi Xuan, Pieper, Michael P., Leung, Janice M., Sin, Don D., Dorscheid, Delbert R.
Publicado 2021